![Q2 Biotech Stocks Expected to See Conference Momentum and Mega-Scale Technology Exports... Ligand Chem & Hanmi Pharm Top Picks [Today's Report]](https://pimg.mk.co.kr/news/cms/202604/16/news-p.v1.20260416.449c8ca7c76947898cfb990e51aee070_R.png)
Q2 Biotech Stocks Expected to See Conference Momentum and Mega-Scale Technology Exports... Ligand Chem & Hanmi Pharm Top Picks [Today's Report]
NH Investment & Securities predicts the biotech sector, which saw frozen investor sentiment due to successive sharp declines in leading stocks, will rebound in Q2, driven by academic conference momentum and mega-scale technology exports.
Key takeaway
"Q2 Biotech Stocks Expected to See Conference Momentum and Mega-Scale Technology Exports... Ligand Chem & Hanmi Pharm Top Picks [Today's Report]" — BullBear's AI rates this story as a bullish (positive) signal for markets, with a market-impact score of 55 out of 100. NH Investment & Securities predicts the biotech sector, which saw frozen investor sentiment due to successive sharp declines in leading stocks, will rebound in Q2, driven by academic conference momentum and mega-scale technology exports. Reported by Maeil Business on April 15, 2026. The call is verified against the actual 24-hour price move on BullBear's public conviction ledger.
Catch the next bull catalyst
Telegram alerts when our AI scores a story 80+/100 impact (~1-3 per day, no spam). Verified 30d hit rate 53.4%.